Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
Public ClinicalTrials.gov record NCT07493096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Functional and Neurodevelopmental Outcomes Following Intensive Multimodal Neurorehabilitation in Pediatric Patients With Neurodevelopmental Disorders, Including Chromosomal Abnormalities
Study identification
- NCT ID
- NCT07493096
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Healing Hope International
- Other
- Enrollment
- 100 participants
Conditions and interventions
Conditions
- 22q11.2 Deletion Syndrome
- Autism Spectrum Disorder
- Autism Spectrum Disorder (ASD
- Cerebral Palsy (CP)
- Cerebral Palsy Hemiparetic Cerebral Palsy Spasticity Gait Disorders, Neurologic Postural Balance Impairment
- Cerebral Palsy Infantile
- Cerebral Palsy Spastic Hemiplegic
- Cerebral Palsy, Dyskinetic
- Chromosomal Abnormalities
- Developmental Delay (Disorder)
- Down Syndrome (Trisomy 21)
- Fragile X Syndrome (FXS)
- Genetic Disorders
- Hypoxic Ischemic Encephalopathy
- Hypoxic Ischemic Encephalopathy (HIE)
- Neurodevelopmental Disorders
- Neurodevelopmental Disorders (NDD)
- Neurodevelopmental Disorders and Developmental Abnormalities
- RETT Syndrome With Proven MECP2 Mutation
- Sensorimotor Integration
- Sensory Processing Disorder
- Traumatic Brain Injury (TBI)
- Williams Syndrome
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 4 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 29, 2036
- Last update posted
- Mar 24, 2026
2026 – 2036
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ability and Beyond | The Woodlands | Texas | 77380 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07493096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07493096 live on ClinicalTrials.gov.